ReviewCancers2023

Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform.

David A Bunsick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.